| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |